Charles River Laboratories | CRL - حساب الفائدة على الديون





حساب الفائدة على الديون تغيير تاريخ
Agilent USD 25M 0 2026-03
Align Technology USD 6.93M 9.11M 2026-03
Bio-Rad Laboratories USD 12.3M 200K 2026-03
Bruker USD 8.1M 11.9M 2025-12
Cardinal Health USD 101M 13M 2026-03
Charles River Laboratories USD 30.34M 3.6M 2026-06
Cigna USD 157.08B 3.82B 2026-06
Concord Medical Services Hldg CNY 84.37M 32.34M 2023-06
CVS Health USD 757M 17M 2026-06
Danaher USD 107M 44M 2026-06
Dentsply International USD 22M 2M 2026-06
Elevance Health USD 364M 7M 2026-06
Humana USD 197M 4M 2026-06
Illumina USD 24M 2M 2026-03
Incyte USD 582K 13K 2026-06
Intrexon USD 2K 5K 2024-06
IQVIA Holdings USD 197M 5M 2026-06
Laboratory Of America USD 61.1M 6M 2026-06
Lakefront Biotherapeutics EUR 1.72M 940K 2025-09
Lonza CHF 84M 14M 2025-06
McKesson USD 77M 18M 2026-06
Merck EUR 104M 17M 2026-03
Mettler Toledo International USD 17.25M 239K 2026-06
Novartis USD 462M 119M 2026-06
Pfizer USD 667M 4M 2026-06
Quest Diagnostics USD 69M 2M 2025-09
Revvity USD 22.99M 1.73M 2026-06
Thermo Fisher Scientific USD 354M 11M 2026-03
United Therapeutics USD 2.9M 200K 2026-06
UnitedHealth USD 962M 7M 2026-06
Veradigm USD 1.25M 641K 2022-09
Waters USD 55M 13M 2026-06
West Pharmaceutical Services USD 1.9M 1.7M 2026-03